M. Cuadrado‐Vilanova

Increased delivery of chemotherapy to the vitreous by inhibition of the blood‐retinal barrier

J. Mora, M. Torrebadell, A. Carcaboso, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Targeted drug distribution in tumor extracellular fluid of GD2‐expressing neuroblastoma patient‐derived xenografts using SN‐38‐loaded nanoparticles conjugated to the monoclonal antibody 3F8

J. Mora, C. Lavarino, N. Cheung, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients

J. Mora, F. Radvanyi, C. Lavarino, 2022, The Journal of pathology.

Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients

J. Mora, F. Radvanyi, C. Lavarino, 2022, The journal of pathology. Clinical research.

Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

J. Mora, C. Lavarino, A. Carcaboso, 2021, The journal of pathology. Clinical research.

Glucosylated nanomicelles target glucose‐avid pediatric patient‐derived sarcomas

J. Mora, A. Carcaboso, A. Sosnik, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

J. Mora, F. Radvanyi, R. Alemany, 2019, Science Translational Medicine.

Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution.

J. Mora, E. de Álava, C. Lavarino, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.

J. Mora, E. de Álava, C. Lavarino, 2023, Biochemical pharmacology.